Severe anaphylactoid reactions during anaesthesia in 116 patients are described. The majority of patients who reacted to induction agents had previous exposure to the drug, while the majority of patients who reacted to muscle relaxants had not. There was a statistically significant increased incidence of allergy, atopy, asthma and previous reactions in patients who had reactions compared with a control group undergoing uneventful anaesthesia. There was no correlation between abnormalities in immunoglobulins or resting complement levels and a history of allergy or atopy. Antihistamines, steroids and bronchodilators alone did not prevent reactions and three patients reacted to test doses with Althesin. Reactions usually occurred during induction of anaesthesia, but may occur at any time in the perioperative period. No one drug produced reactions that differed in severity or clinical features from any other drug. Clinical features included skin changes, oedema, cardiovascular collapse, bronchospasm, gastrointestinal symptoms, prolonged unconsciousness, convulsions and pulmonary oedema. Four patients died.
MATERIALS AND METHODS One hundred and forty-two patients were referred because of a reaction related to anaesthesia which the anaesthetist considered anaphylactoid. Evidence that a reaction was not anaphylactoid was based on one or more of the following: 1. Reaction involving one organ system. 2. Uneventful subsequent anaesthesia with the same drugs. 3. Negative skin test. 4 . No changes in sequential complement measurements. 5. Strong history suggestive of alternative cause. A reaction was attributed to a particular drug on the basis of the drug being the sole agent, a positive reaction to intradermal testing, passive transfer testing, or challenge.
Immunoglobulin levels, at least one month after reactions, were measured by radial immunodiffusion and radio-immunoassay in 68 patients. Complement levels, C3 and C4 levels in 71 patients, and Ch50 in ten patients, were measured by radial immunodiffusion using monospecific antigen.
Intradermal testing and passive transfer testing were carried out using methods described previously. 3, 4 The reactions were classified according to severity using following classification -1. Trivialreaction confined to skin or not requiring treatment. Such patients have been excluded in this study.
Majorreaction requiring resuscitation
with cardiopulmonary function restored within 60 minutes. 3. Severereactions requiring prolonged resuscitation with severe bronchospasm, prolonged hypotension or cardiac arrest.
RESULTS EPIDEMIOLOGY
One hundred and sixteen patients were diagnosed as having severe anaphylactoid reactions. Table 1 shows the number of reactions attributed to specific drugs, the sex of the patients, previous exposure, severity, and the number of patients who underwent subsequent uneventful anaesthesia.
The difference in the incidence of previous exposure to anaesthesia or the specific drug in patients who reacted to relaxants was statistically different from the incidence in patients who reacted to induction agents (p = 0.001 Chi squared). There were differences in the sex of patients reacting to particular drugs but the numbers were too small to achieve significance. Table 2 shows the type of operations the patients were having and whether major or minor. Sixty operations were abandoned because of the reaction.
There was a statistically significant increase in the incidence of allergy, atopy, asthma and previous reaction to anaesthesia between patients who had reactions and a control group of 1000 patients undergoing uneventful anaesthesia (Table 3 ). However, there was no correlation between abnormalities in immunoglobulins or resting complement levels and a history of allergy or atopy (Table 4) . Twenty-three females had a history of allergy to cosmetics. The average age of the patients was 
NON ANAPHYLACTOID REACTIONS
In 26 cases the diagnosis of an anaphylactoid reaction was dismissed and 18 of these patients had the same anaesthetic uneventfully on a subsequent occasion. The probable causes of these reactions are shown in Table 5 . 
CLINICAL FEATURES
The clinical features of the reactions to a particular drug are shown in Table 6 . No drug appeared more likely to produce a particular feature than any other. The most lifethreatening clinical feature was oedema in five patients, cardiovascular collapse in 96 and bronchospasm in 15. Nine patients had reactions involving one organ system. Severity was not related to the drug used. The first clinical feature noted is shown in Table 7 .
The individual clinical features were: 1. Subjective symptoms Eight patients had reactions while awake. Two of these had no subjective symptoms. The others complained of abdominal discomfort (4), gustatory symptoms (3), and racing pulse (1). were available in 68 patients. Two showed no change in ECG, five sinus bradycardia and one patient had atrial fibrillation prior to and during the reaction. The remaining 60 showed predominantly sinus tachycardia and 15 showed other abnormalities. ST segment change occurred in 11 and ventricular tachycardia in six. The ventricular tachycardia was probably due to intravenous adrenaline in three patients. Two of the remainder had moderately severe cardiac disease. One patient with cardiac disease developed atrial fibrillation during the reaction, and reverted spontaneously. Eleven patients had cardiac arrests, one patient on two occasions. Details of 12 arrests were available and seven of these were in asystole and four ventricular fibrillation. Seven of the asystolic arrests were preceded by bradycardia following supraventricular tachycardia.
Cutaneous symptoms
Pulmonary oedema was diagnosed in three patients on X-ray and found at post mort em in two. In all cases the pulmonary oedema was not severe and was not recognised clinically.
Bronchospasm
(a) In 20 patients the anaesthetist noted a transient difficulty in inflating the patient prior to inserting the endotracheal tube, and the patient did not develop bronchospasm. None of these patients was asthmatic prior to reaction. (b) Severe bronchospasm occurred in 25 patients including three of the four fatal cases. It was usually the most difficult feature to treat. Of the patients who developed bronchospasm 19 were asthmatics and two had histories of severe hay fever.
Gastrointestinal symptoms
Nineteen patients developed cramping abdominal pain, nausea, vomiting and diarrhoea which persisted up to 12 hours in the recovery period. One of these patients had recurrent attacks of diarrhoea and cramping pain over a week. In two patients the diarrhoea was bloodstained and in one the vomitus contained bright blood. The gastrointestinal symptoms occurred irrespective of therapy used in the acute episode and did not respond to antihistamines, antiemetics, antispasmodics, or antacids.
Oliguria
Oliguria was noted postoperatively in 14 patients and 12 were given diuretics. In all these patients a massive diuresis occurred eventually although it appeared to be more related to fluid therapy than diuretic administration. No patient developed evidence of renal impairment.
Other features
Two patients developed clonic convulsions in the limbs and two developed transient pyrexia. Unconsciousness for more than four hours occurred in ten patients. Two patients had laryngeal stridor associated with angioneurotic oedema.
Post operative complications
Six patients developed venous thrombosis and seven developed wound haematomata.
Two patients developed persistent
Anaesthesia and Intensive Care, Vol. IX. No. 3, August. 1981 headaches lasting up to 12 weeks, and one patient in whom no operation was performed had watery vaginal discharge and gastrointestinal cramps for seven days. One patient with menorrhagia, who was to have a hysterectomy which was not performed, had no further menorrhagia.
Permanent sequelae
Three patients sustained brain damage and four died. Post mortem examination of the patients showed pulmonary oedema and acute emphysema in three and no abnormality in one.
Duration of reactions
The average time to restore blood pressure and ventilation to normal was 143 minutes. Seven patients were in intensive therapy units for three days or longer.
DISCUSSION
Anaphylactoid reactions are an important cause of morbidity and mortality in anaesthesia. The incidence in Australasia is between 1:5000 and 1:25000 anaesthetics and the mortality in this series is 3.4% which is similar to the British series of Clarke et al. 5 Drug sensitivity was implicated in 4.30/0 of deaths and 5.6% of cerebral damage in cases of anaesthetic mishap reported to the Medical Defence Union in the United Kingdom. 6 Although the incidence of a history of allergy, atopy, asthma and previous reaction is higher in patients who had anaphylactoid reactions than in the general population, it is not of sufficient magnitude to make feasible the pretreatment of all patients with a history of allergy. The measurement of immunoglobulins and complement levels does not identify an atrisk group.
The sex of patients reacting to individual drugs is not statistically different.
The history of previous exposure in patients reacting to induction agents is similar to that described by Clarke. 7 However, the lack of previous exposure in patients reacting to relaxants suggests some other antigen has sensitised the patient. Positive intradermal tests suggests an IgE mediated reactionS which requires previous sensitisation. The high incidence of sensitivity to cosmetics suggests that this may be a factor in some patients.
With the exception of Althesin the incidence of reactions probably reflects usage rather than a greater danger from a particular drug. It is generally agreed that the risk of reactions with Althesin and prop ani did is greater than with other drugs and the published figures confirm this (Table 8 ). The premedication figures show that steroids or antihistamines alone will not protect from anaphylactoid reactions. There is evidence that in combination they may protect. 18 Test doses have been suggested as advisable in prevention '6 but with contrast media,'9 antibiotics 20 and Althesin 21 this has been shown to be unreliable and hazardous -findings confirmed in this study.
It is important to appreciate that although the reactions usually occur during induction they may occur at any time in the perioperative period and the onset may be delayed. When more than one drug is used it is hazardous to attribute the reaction to a particular drug on a time basis.
Subsequent exposure to anaesthesia is safe if the offending drug is identified and avoided. This presupposes adequate communication. No patient has had a severe reaction during a subsequent anaesthetic after referral, including those in whom a cause could not be determined.
Vehicles, additives and contaminants other than active drug may cause the reactions and this has been shown with dextrans and steroids. Vehicles and preservatives were skin-tested independently in this series, and the reaction was due to active drug with the exception of cremophor.
All the clinical features produced by anaphylactoid reactions may be produced by other mechanisms during anaesthesia. Although a careful history may suggest the nature of the reaction, and even the drug responsible, it is not always reliable. A particularly difficult problem, for example, is the patient who develops head and neck swelling during surgery of the neck or throat where the cause may be mechanical or anaphylactoid.
Rashes and wheals are common in uneventful anaesthesia, occurring in 20-30% of patients 22 but generalised flushing may be a harbinger of subsequent problems. Bronchospasm and laryngospasm are usually related to stimulation of the air passages during light anaesthesia 23 • 24 and hypotension to vasodilation or cardiac depression.
True anaphylactoid reactions usually involve more than one organ system, although syndromes, such as carcinoid, may cause symptoms involving skin and cardiovascular system. The high incidence of cutaneous phenomena in uneventful anaesthesia compounds the difficulty in determining whether a reaction involving skin and one other system is an anaphylactoid reaction.
The clinical features of anaphylactoid reactions are due to the production and release of endogenous vasoactive substances, the chief of which is histamine. Although all the clinical features of anaphylactoid reactions may be produced by histamine infusion, fatal reactions may occur in which histamine levels are not elevated. 25 Other mediators known to modify, amplify and cause such reactions are slow releasing substance of anaphylaxis, serotonin, bradykinin, prostaglandins, eosinophil and neutrophil factor, platelet aggregating factor 26 and complement split products.
The effects of histamine are: 27 1. vasodilation, 2. increased capillary permeability, 3. smooth muscle contraction, 4. increased exocrine gland secretion, 5. inhibition of release of mediators, lymphokines, and lysosymes from white cells,26 6. possible direct cardiac effects.
Two of the effects are controversial. The effects on capillary permeability in the lung may be either in the pulmonary or bronchial circulation. 29 Further, the intra-alveolar oedema occurring in the lung may be related solely to high intra-alveolar pressure.
In the guinea pig model the heart is a target organ and histamine release occurs from the heart both in the vivo and vitro. 28 Lichtenstein suggests that cardiac death in human anaphylaxis is due to histamine. 26 Smedegard showed that during aggregate and cytotrophic anaphylaxis in monkeys there was no primary depression of cardiac function as an important factor in the development of shock. 30 The distribution of clinical features in the patients described is similar to that of 336 cases of reactions to induction agents described by Clarke. 7 Like Garrett 31 we are unable to link particular symptoms, symptom complexes, or severity to a particular drug. The only clinical feature that appears relatively predictable is severe bronchospasm which is usually associated with a past history of asthma. This could be expected, as patients with asthma have increased bronchial reactivity to histamine, a phenomenon which occurs to a lesser degree in patients with hay fever. 32 The transient difficulty in inflation that is commonly described has been shown to be due to bronchospasm. 33 As its timing is J'la.rIy it is probably related to the effects of pe",k levels of mediator acting on bronchial musculature with normal reactivity.
The late generalised oedema that occurs may be related to crystalloid therapy rather than the reaction per se.
Whether anaphylactoid mediators cause cardiac depression is a subject of conjecture. In these patients cardiac failure and atrial fibrillation only occurred in association with cardiac disease and ventricular fibrillation after intravenous adrenaline. The other ECG abnormalities noted could all be secondary to hypoxaemia and acidosis. The characteristic circulatory features are a reduction in circulating blood volume due to vasocUlatation and fluid loss.3o, 34 The incidence of wound haematoJlla and deep vein thrombosis is greater thl:j.n after uneventful surgery. Watkins 35 notes that haematological abnormalities occur in 10-150/0 Anaesthesia and Intensive Care, Vol. IX, No. 3, August, 1981 of patients who have anaphylactoid reactions. Smith et al. 36 noted intravascular coagulation in two patients with severe reactions. In view of these findings it would seem prudent to abandon surgery when severe reactions occur.
Anaphylactoid reactions must be considered in the diagnosis of untoward events during anaesthesia and adequate investigation undertaken to determine the cause of the event and the drug responsible. It is probable that any drug that is injected can cause an anaphylactoid reactionY
